Antibacterial Activity of Cefditoren Against Major Community-Acquired Respiratory Pathogens Recently Isolated in Italy

References

• Mandell LA. Antimicrobial resistance and treatment of community-acquired pneumonia. Clin. Chest Med. 2005; 26 (1): 57–64.
   PubMed Web of Science ®Google Scholar
• Alpuche C, Garau J, Lim V. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens. : Int. J. Antimicrob. Agents. 2007; 30 Suppl 2: S135–8.
   PubMedGoogle Scholar
• Bisno AL. Acute pharyngitis.N Engl J Med. 2001; 344 (3): 205–11.
   PubMed Web of Science ®Google Scholar
• Passali D, LaurieIto M, Passali GC, Passali FM, Bellussi L. Group A streptococcus and its antibiotic resistance. Acta Otorhi-nolaryngol. Ital. 2007; 27 (1): 27–32.
   PubMedGoogle Scholar
• Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial re-sistance in Haemophilus influenzae. Clin. Microbiol. Rev. 2007; 20 (2): 368–89.
   PubMed Web of Science ®Google Scholar
• Verduin CM, Hol C, Reer A, van Dijk H, van Belkum A. Moraxella catarrhalis: from emerging to established pathogen. Clin. Microbiol. Rev. 2002; 15 (1): 125–44.
   PubMed Web of Science ®Google Scholar
• Felmingham D. Comparative antimicrobial susceptibility of respiratory tract pathogens. Chemotherapy. 2004; 50 Suppl 1: 3–10.
   PubMed Web of Science ®Google Scholar
• de Lencastre H, Oliveira D, Tomasz A. Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. Curr Opin Microbiol. 2007; 10 (5): 428–35.
   PubMed Web of Science ®Google Scholar
• Appelbaum PC. Microbiology of antibiotic resistance in Staphylococcus aureus. Clin Infect Dis. 2007; 45 Suppl 3: S165–70.
   PubMedGoogle Scholar
• Paterson DL. Resistance in gram-negative bacteria: En-terobacteriaceae. Am J Infect Control. 2006; 34(5 Suppl 1): S20-8; discussion S64-73.
   Google Scholar
• Perez F, Endimiani A, Hujer KM, Bonomo RA. The con-tinuing challenge of ESBLs. Curr Opin Pharmacol. 2007 Oct; 7 (5): 459-69. Epub 2007 Sept 17.
   Google Scholar
• Darkes MJ, Plosker GL. Cefditoren pivoxil. Drugs. 2002; 62 (2): 319-36; discussion 337-8.
   Google Scholar
• Wellington K, Curran MP. Spotlight on cefditoren pivoxil in bacterial infections. Treat Respir Med. 2005; 4 (2): 149–52.
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute (CLSI). Per-formance standards for antimicrobial susceptibility testing: sev-enteenth informationals supplement. CLSI document M100-517.CLSI, Wayne, Pennsylvania 2007.
   Google Scholar
• Tamura A, Okamoto R, Yoshida T, Yamamoto H, Kondo S, Inoue M et al. In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin. Antimicrob Agents Chemother. 1998 Sep; 32 (9): 1421-6.
   Google Scholar
• Jones RN, Pfaller MA, Jacobs MR, Appelbaum PC, Fuchs PC. Cefditoren in vitro activity and spectrum: a review of inter-national studies using reference methods. Diagn Microbiol Infect Dis. 2001; 41(1-2):1–14.
   PubMed Web of Science ®Google Scholar
• Reinert RR, Al-Lahham A, Ltitticken R. In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae iso-lated in Germany, 1992-1998. J Antimicrob Chemother. 2001; 48 (2): 279–81.
   PubMed Web of Science ®Google Scholar
• Clark CL, Nagai K, Dewasse BE, Pankuch GA, Eclnie LM, Jacobs MR, Appelbaum PC. Activity of cefditoren against respi-ratory pathogens. J Antimicrob Chemother. 2002; 50 (1): 33–41.
   PubMed Web of Science ®Google Scholar
• Lee MY, Ko KS, Oh WS, Park S, Lee JY, Baek JY et al. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries. Int J Antimicrob Agents. 2006; 28 (1): 14–8.
   PubMed Web of Science ®Google Scholar
• Fenoll A, Giménez MJ, Robledo 0, Coronet P, Gimeno M, Casal J et al. Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to peni-cillins, cephalosporins, macrolides, ketolides or quinolones. Int J Antimicrob Agents. 2007; 29 (2): 224-6.
   Google Scholar
• Perez-Trallero E, Marimon JM, Ercibengoa M, Gimenez MJ, Coronet P, Aguilar L. Antimicrobial susceptibilities of amoxy-cillin-non-susceptible and susceptible isolates among penicillin-non-susceptible Streptococcus pneumoniae. Clin Microbiol Infect 2007; 13 :937–940.
   PubMed Web of Science ®Google Scholar
• Cafini F, Aguilar L, Alou L, Giménez MJ, Sevillano D, Torrico M et al. Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity. Eur J Clin Microbiol Infect Dis. 2008; 26.
   Google Scholar
• Sevillano D, Aguilar L, Alou L, Giménez MJ, Gonzalez N, Echeverria 0 et al. Beta-lactam activity against penicillin-resis-tant Streptococcus pneumoniae strains exhibiting higher amox-icillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation. Chemotherapy. 2008; 54 (2): 84-90.
   Google Scholar
• Schito GC. Is antimicrobial resistance also subject to glob-alisation? Clin Microbiol Infect 2002; 8 Suppl 3: 1-8; discussion 33-5.
   Google Scholar
• Marchese A, Schito GC. Role of global surveillance in combating bacterial resistance. Drugs. 2001; 61; 167–73.
   PubMed Web of Science ®Google Scholar
• Boccia D, D'Ancona F, Salmaso S, Monaco M, Del Grosso M, D'Ambrosio F et al. Antibiotic-resistance in Italy: ac-tivity of the first year of the surveillance project AR-ISS. Ann lg. 2005; 17 (2): 95–110.
   Google Scholar
• Marchese A, Gualco L, Cochetti I, Montanan MP, Spe-ciale AM, Musumeci SR et al. Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). Int J Antimicrob Agents. 2005; 138-45.
   Google Scholar
• Cascone C, Mezzatesta ML, Santagati M, Cafiso V, Nico-letti G, Stefani S. Activity of telithromycin against multi-drug re-sistant Streptococcus pneumoniae and molecular characterization of macrolide and tetracycline resistance deter-minants. J Chemother. 2005; 17 (5): 502–8.
   PubMed Web of Science ®Google Scholar
• Marchese A, Ardito F, Fadda G, Gualco L, Mezzatesta M, Nicoletti G et al. Protekt Italia. Analisi dei risultati del terzo e ul-timo anno di studio (2004) e considerazioni conclusive. GIM-MOC. 2005; Vol. IX, n.2: 69–106
   Google Scholar
• Monaco M, Camilli R, D'Ambrosio F, Del Grosso M, Pan-tosti A. Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy. J Antimicrob Chemother 2005; 55, 256–259.
   PubMed Web of Science ®Google Scholar
• Mazzariol A, Koncan R, Bahar G, Cornaglia G. Suscepti-bilities of Streptococcus pyogenes and Streptococcus pneumo-niae to macrolides and telithromycin: data from an Italian multicenter study. J Chemother 2007; 19 (5): 500–7.
   PubMed Web of Science ®Google Scholar
• Varaldo PE, Debbia EA, Nicoletti G, Pavesio D, Ripa S, Schito GC et al. Nationwide survey in Italy of treatment of Strep-tococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. Clin Infect Dis 1999; 29 (4): 869-73.
   Google Scholar
• Cascone C, Santagati M, Noviello S, lannelli F, Esposito S, Pozzi G et al. Macrolide- resistance genes in clinical isolates of Streptococcus pyogenes Microb Drug Resist. 2002; 8 (2): 129–32.
   PubMed Web of Science ®Google Scholar
• Gagliotti C, Nobilio L, Milandri M, Moro ML. for the Emilia-Romagna Antibiotic Resistance Study Group. Macrolide prescriptions and erythromycin resistance of Streptococcus pyo-genes. Antimicrob Agents Chemother 2006; 42: 1153–56.
   Google Scholar
• Creti R, Imperi M, Baldassarri L, Pataracchia M, Recchia S, Alfarone G et al. emm Types, virulence and antibiotic resi-tance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years? J Clin Microbiol. 2007; 45 (7): 2249-2256.
   Google Scholar
• Stefani S, Varaldo PE. Epidemiology of methicillin-resis-tant staphylococci in Europe. Clin Microbiol Infect 2003; 9 (12): 1179–86.
   PubMed Web of Science ®Google Scholar
• Blandino G, Marchese A, Ardito F, Fadda G, Fontana R, Lo Cascio G et al. Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolates in Italy from patients with hospital-acquired infections. Int J An-tiimicrob Agents 2004; 24 (5): 515-8.
   PubMed Web of Science ®Google Scholar
• Monaco M, Antonucci R, Palange P, Venditti M, Pantosti A. Methicillin-resistant Staphylococcus aureus necrotizing pneu-monia. Emerg Infect Dis. 2005 Oct; 11 (10): 1647–8.
   PubMed Web of Science ®Google Scholar
• Nicoletti G, Blandino G, Caccamo F, Fruscia 0, Schito AM, Speciale A; Italian Epidemiologial Observatory. The Italian Epidemiological Survey 1997-1999. Antimicrobial susceptibility data of Haemophylus influenzae, Haemophylus parainfluen-zae and Moraxella catarrhalis in Italy. Int J Antimicrob Agents. 2002; 20 (4): 263-9.
   Google Scholar
• Schito AM, Schito GC, Debbia E, Russo G, Lifores J, Cercenado E et al. Antibacterial resistance in Streptococcus pneumoniae and Haemophylus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000. J Chemother 2003; 15 (3): 226-34.
   Google Scholar
• Cerquetti M, Cardines R, Giufré M, Mastrantonio P; HI Study Group. Antimicrobial susceptibility of Haemophilus in-fluenzae strains isolates from invasive diseases in Italy. J An-timicrob Chemother 2004; 54 (6): 1139–43.
   PubMed Web of Science ®Google Scholar
• Jansen WT, Verel A, Beitsma M, Verhoef J, Milatovic D. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J Antimicrob Chemother. 2006; 58 (4): 873–7.
   PubMed Web of Science ®Google Scholar
• Bonfiglio G, Perilli M, Stefani S, Amicosante G, Nicoletti G. Prevalence of extended spectrum beta-lactamases among En-terobacteriaceae: an Italian survey. Int J Antimicrob Agents. 2002; 19 (3): 213–7.
   PubMed Web of Science ®Google Scholar
• ” Luzzaro F, Mezzatesta M, Mugnaioli C, Perilli M, Stefani S, Amicosante G et al. Trends in production of extended-spec-trum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J Clin Microbiol 2006; 44 (5): 1659-64.
   Google Scholar
• Mugnaioli C, Luzzaro F, De Luca F, Brigante G, Perilli M, Amicosante G et al. CTX-M-type extended-spectrum beta-lacta-mases in Italy: molecular epidemiology of an emerging country-wide problem. Antimicrob Agents Chemother 2006; 50 (8): 2700–6.
   Google Scholar
• Carattoli A, Garcia-Fernandez A, Varesi P, Fortini D, Ger-ardi S, Penni A et al. Molecular epidemiology of Escherichia coli producing extended beta-lactamases isolated in Rome, Italy. J Clin Microbiol 2008; 46 (1): 103-8.
   Google Scholar
• Pérez-Trallero E, Marimón JM, Ercibengoa M, Giménez MJ, Coronel P, Aguilar L. Antimicrobial susceptibilities of amoxy-cillin-non-susceptible and susceptible isolates among penicillin-non-susceptible Streptococcus pneumoniae. Clin Microbiol Infect. 2007; 13: 937–40.
   PubMed Web of Science ®Google Scholar
• Fenoll A, Giménez MJ, Robledo 0, Aguilar L, Tarragó D, Granizo JJ et al. Influence of penicillin/amoxicillin non-suscepti-bility on the activity of third-generation cephalosporins against Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis. 2008; 27 (1): 75-80.
   Google Scholar
• Yamada M, Watanabe T, Miyara T, Baba N, Saito J, Takeuchi Y et al. Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2X: struc-tural basis for its high antimicrobial activity. Antimicrob Agents Chemother. 2007; 51 (11): 3902-7.
   Google Scholar
• Karlowsky JA, Jones ME, Draghi DC, Critchley IA, Thornsberry C, Sahm DF. In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren. Diagn Microbiol Infect Dis. 2002; 42 (1): 59–64.
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Critchley IA, Draghi DC, Jones ME, Thornsberry C, Sahm DF. Activity of cefditoren against beta-lac-tamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalis. Diagn Microbiol Infect Dis. 2002; 42 (1): 53–8.
   PubMed Web of Science ®Google Scholar
• Fenoll A, Aguilar L, Robledo 0, Giménez MJ, Tarragó D, Granizo JJ et al. Influence of the beta-lactam resistance phe-notype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae re-covered from children with acute otitis media. J Antimicrob Chemother. 2007; 60 (2): 323-7.
   Google Scholar
• Jones RN, Biedenbach DJ, Johnson DM. Cefditoren ac-tivity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods. Diagn Mi-crobiol Infect Dis. 2000; 37 (2): 143–6.
   PubMed Web of Science ®Google Scholar
• Darkes MJ, Plosker GL. Cefditoren pivoxil. Drugs. 2002; 62: 319–361
   PubMed Web of Science ®Google Scholar
• Wellington K, Curran MP. Cefditoren pivoxil: a review of its use in the treatment of bacterial infections. Drugs. 2004; 64 (22): 2597–618.
   PubMed Web of Science ®Google Scholar
• Alvarez-Sala JL, Kardos P, Martinez-Beltran J, Coronel P, Aguilar L. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil. Antimicrob Agents Chemother. 2006; 50 (5): 1762–7.
   PubMed Web of Science ®Google Scholar
• Granizo JJ, Giménez MJ, Barberan J, Coronel P, Gimeno M, Aguilar L. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Strep-tococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Clin Ther. 2006; 28 (12): 2061–9
   PubMed Web of Science ®Google Scholar
• Anzueto A, Bishai WR, Pottumarthy S. Role of oral ex-tended-spectrum cephems in the treatment of acute exacerba-tion of chronic bronchitis. Diagn Microbiol Infect Dis. 2007; 57 (3 Suppl): 315–385. Review.
   Google Scholar
• Esposito S, Ianniello F, Noviello S, Leone S, Ascione T, Tice A et al. Outpatient Parenteral Antibiotic Therapy (OPAT): the Italian registry. Infez Med. 2002; 3: 169–75.
   Google Scholar